US FDA authorises Moderna, Pfizer updated Covid boosters for 6 months old
THE US Food and Drug Administration on Thursday (Dec 8) authorised updated Covid-19 booster shots from Moderna and Pfizer and its partner BioNTech for children as young as 6 months of age.
The amended authorisations allow use of Moderna’s bivalent shot in children 6 months through 5 years of age, while the Pfizer/BioNTech vaccine can be given to those aged 6 months through 4 years.
Pfizer’s shot can be administered as the third shot for those eligible and have not completed their primary vaccination series, the agency added. REUTERS
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Share with us your feedback on BT's products and services